How Pharmacists Could Confirm if a Patient’s Genes are a Good Fit for a Drug
-
Tuesday, May 7, 2024
-
11:00 a.m. – 12:00 p.m.
Pharmacogenomics (PGx) presents an enormous opportunity in personalized medicine to maximize clinical benefit and minimize safety risk. At the point of prescription fulfillment, however, pharmacists have little insight into the potential risk or efficacy of a drug based on their patients’ genetic profile, which could result in suboptimal care. This presentation delivered by clinical and drug-knowledge experts describes how pharmacist workflows could be seamlessly updated with pharmacogenomics information to keep patients safe and improve prescribing decisions.
Track Session Speakers
- Anna Dover, Pharm.D., BCPS
- Director, Product Management
-
- FDB (First Databank, Inc.)
|
- Julie Suko, Pharm.D.
- Vice President, Editorial Content
-
- FDB (First Databank, Inc.)
|
- Jason Reed, Pharm.D
- Senior Director, Product Management
-
- FDB Vela
|
|